Antiangiogenic nanotherapy with lipase-labile Sn-2 fumagillin prodrug

By Pan Dipanjan   Sanyal Nibedita   Schmieder Anne H   Senpan Angana   Kim Benjamin   Yang Xiaoxia   Hu Grace   Allen John S   Gross Richard W   Wickline Samuel A   Lanza Gregory M  

Nanomedicine, Vol. 7, Iss. 10, 2012-10 ,pp. : 1507-1519

Future Medicine

Access to resources Recommend Favorite

Synergistic effect of antiangiogenic nanotherapy combined with methotrexate in the treatment of experimental inflammatory arthritis

By Zhou Hui-fang   Hu Grace   Wickline Samuel A   Lanza Gregory M   Pham Christine TN  

Nanomedicine, Vol. 5, Iss. 7, 2010-09 ,pp. : 1065-1074

Future Medicine

Access to resources Recommend Favorite

Therapeutic potential of antiangiogenic agents for prevention and treatment of obesity

By Cao Yihai   Cao Renhai   Xue Yuan  

Future Lipidology, Vol. 3, Iss. 2, 2008-04 ,pp. : 153-162

Future Medicine

Access to resources Recommend Favorite

Obesity: taking control

By Godson Ros  

Community Practitioner, Vol. 79, Iss. 7, 2006-07 ,pp. : 208-209

Community Practitioner

Access to resources Recommend Favorite

Ventilation and Its Control during Incremental Exercise in Obesity

By  

Respiration, Vol. 75, Iss. 1, 2006-11 ,pp. : 26-33

Karger

Access to resources Recommend Favorite